title: Neuroprotective effects of inhibitors of dipeptidyl peptidase-iV in vitro and in vivo.
authors.affiliation: Guilford Pharmaceuticals, Inc., Tributary St., Baltimore, MD, USA.
authors.forename: Yong-Qian
authors.initials: YQ
authors.lastname: Wu
authors.forename: David C
authors.initials: DC
authors.lastname: Limburg
authors.forename: Douglas E
authors.initials: DE
authors.lastname: Wilkinson
authors.forename: Paul
authors.initials: P
authors.lastname: Jackson
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Steiner
authors.forename: Gregory S
authors.initials: GS
authors.lastname: Hamilton
authors.forename: Sergei A
authors.initials: SA
authors.lastname: Belyakov
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology; D000818:Animals; D016923:Cell Death / Q000187:drug effects; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism*; D051379:Mice; D009046:Motor Neurons / Q000166:cytology / Q000187:drug effects / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000517:prevention & control*; D011480:Protease Inhibitors / Q000494:pharmacology*
chemical_list: D018696:Neuroprotective Agents; D011480:Protease Inhibitors; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D018819:Dipeptidyl Peptidase 4